Inspira Technologies Oxy BHN (IINN) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Inspira Technologies Oxy BHN Ltd., a medical technology innovator, has announced the FDA 510(k) clearance of its INSPIRA ART100 Cardiopulmonary Bypass System, marking a significant milestone in the company’s progress. This breakthrough device, featuring Adaptive Blood Oxygenation technology, aims to improve patient oxygen saturation levels and could potentially reduce the need for mechanical ventilation. The clearance by FDA is seen as a testament to the company’s technological and innovative advancements in the life support arena.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.